SG Americas Securities’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55K Sell
32,797
-1,639
-5% -$2.91K ﹤0.01% 3017
2025
Q4
$49K Buy
34,436
+22,492
+188% +$32.8K ﹤0.01% 3358
2025
Q3
$20K Buy
+11,944
New +$13.3K ﹤0.01% 3288
2025
Q2
Sell
-65,336
Closed -$53K 3021
2025
Q1
$53K Buy
65,336
+17,759
+37% +$20.4K ﹤0.01% 3231
2024
Q4
$66K Buy
47,577
+5,085
+12% +$5.7K ﹤0.01% 2852
2024
Q3
$44K Sell
42,492
-81,085
-66% -$111K ﹤0.01% 3269
2024
Q2
$214K Buy
123,577
+106,052
+605% +$213K ﹤0.01% 2139
2024
Q1
$42K Sell
17,525
-55,649
-76% -$137K ﹤0.01% 2789
2023
Q4
$244K Buy
+73,174
New +$196K ﹤0.01% 1983
2023
Q2
Sell
-27,124
Closed -$186K 2413
2023
Q1
$186K Buy
+27,124
New +$211K ﹤0.01% 2467
2022
Q3
Sell
-71,068
Closed -$515K 3222
2022
Q2
$515K Buy
71,068
+27,173
+62% +$236K 0.01% 1934
2022
Q1
$567K Sell
43,895
-35,344
-45% -$449K ﹤0.01% 1807
2021
Q4
$1.26M Sell
79,239
-6,961
-8% -$122K 0.01% 1464
2021
Q3
$1.39M Buy
+86,200
New +$1.26M 0.01% 1624
2021
Q2
Sell
-18,601
Closed -$272K 2895
2021
Q1
$272K Buy
18,601
+9,815
+112% +$167K ﹤0.01% 2456
2020
Q4
$153K Sell
8,786
-37,212
-81% -$663K ﹤0.01% 2790
2020
Q3
$844K Buy
45,998
+4,043
+10% +$75.2K 0.01% 1286
2020
Q2
$749K Buy
41,955
+23,306
+125% +$394K 0.01% 1697
2020
Q1
$302K Buy
18,649
+8,719
+88% +$161K ﹤0.01% 2226
2019
Q4
$179K Buy
+9,930
New +$183K ﹤0.01% 2557
2019
Q2
Sell
-7,916
Closed -$108K 3119
2019
Q1
$108K Buy
+7,916
New +$106K ﹤0.01% 3015
2017
Q4
Sell
-11,705
Closed -$156K 3237
2017
Q3
$156K Buy
11,705
+4,461
+62% +$59K ﹤0.01% 2807
2017
Q2
$104K Buy
7,244
+1,785
+33% +$34.3K ﹤0.01% 2891
2017
Q1
$115K Sell
5,459
-10,778
-66% -$265K ﹤0.01% 2882
2016
Q4
$457K Buy
16,237
+8,536
+111% +$239K ﹤0.01% 1761
2016
Q3
$206K Buy
+7,701
New +$210K ﹤0.01% 2472

Other funds holding CHRS